AccuSift provides high-performance hydrochlorothiazide competitive assay pairings, characterized by exceptional batch-to-batch consistency and optimized for IVD kit development (Lateral Flow, Chemiluminescence, ELISA, POCT). These pairings offer high affinity and specificity, facilitating rapid detection.Hydrochlorothiazide is a thiazide diuretic compound. In major international and domestic sports events, diuretics such as hydrochlorothiazide are important targets for testing. The substance itself lacks stimulant effects, but by increasing urine output, it can be used to reduce body weight before competitions or dilute prohibited substances in urine, thus it is also listed among prohibited substances.On October 27, 2017, the World Health Organization’s International Agency for Research on Cancer (IARC) listed hydrochlorothiazide in its preliminary compilation of Group 2B carcinogens. In November 2024, hydrochlorothiazide was reclassified as a Group 1 carcinogen.Performance Characteristics:
Sensitivity: ELISA IC50: 0.2 ppb
Source: Mouse Monoclonal Antibody
Recommended Pairing: (Coating) / (Labeling)
Storage: Long‑term storage at ≤ –20°C; short‑term storage at 2–8°C. Shipped on ice packs.
WeChat
